Ascendis Pharma A/S vs IAC/Interactivecorp — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while IAC/Interactivecorp trades at $40.21 (market cap $2.97B). The key difference: Ascendis Pharma A/S is far larger — about 5.6× IAC/Interactivecorp's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, IAC/Interactivecorp nearer its low. Which is the better fit depends on your goals.
| ASND | PPLI | |
|---|---|---|
Market Cap | $16.67B | $2.97B |
Sector | Health | Media |
52-Week High | $277.18 | $47.62 |
52-Week Low | $189.74 | $31.52 |
Enterprise Value | $17.04B | $3.28B |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →